![Consensus guidelines of ECCO/ESPGHAN on the medical management of pediatric Crohn's disease - ScienceDirect Consensus guidelines of ECCO/ESPGHAN on the medical management of pediatric Crohn's disease - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1873994614001482-gr2.jpg)
Consensus guidelines of ECCO/ESPGHAN on the medical management of pediatric Crohn's disease - ScienceDirect
Charlie Lees on Twitter: "With earlier biological prescribing in Crohn's disease • fewer operations • longer time to first operation Note how the shape of the biologic curve changes from 2014-2017 https://t.co/C5GpCwCr70
![PDF) Second N-ECCO Consensus Statements on the European Nursing Roles in Caring for Patients with Crohn's Disease or Ulcerative Colitis | Usha Chauhan - Academia.edu PDF) Second N-ECCO Consensus Statements on the European Nursing Roles in Caring for Patients with Crohn's Disease or Ulcerative Colitis | Usha Chauhan - Academia.edu](https://0.academia-photos.com/attachment_thumbnails/66568822/mini_magick20210422-30260-ogobno.png?1619150270)
PDF) Second N-ECCO Consensus Statements on the European Nursing Roles in Caring for Patients with Crohn's Disease or Ulcerative Colitis | Usha Chauhan - Academia.edu
Costs and Resource Utilization for Diagnosis and Treatment During the Initial Year in a European Inflammatory Bowel Disease Ince
![PDF) Consensus guidelines of ECCO/ESPGHAN on the medical management of pediatric Crohn's disease | Jiri Bronsky, Jorge Amil, Jaroslaw Kierkus, Gábor Veres, and Johanna Escher - Academia.edu PDF) Consensus guidelines of ECCO/ESPGHAN on the medical management of pediatric Crohn's disease | Jiri Bronsky, Jorge Amil, Jaroslaw Kierkus, Gábor Veres, and Johanna Escher - Academia.edu](https://0.academia-photos.com/attachment_thumbnails/40333028/mini_magick20190221-19344-hsnm4k.png?1550766493)
PDF) Consensus guidelines of ECCO/ESPGHAN on the medical management of pediatric Crohn's disease | Jiri Bronsky, Jorge Amil, Jaroslaw Kierkus, Gábor Veres, and Johanna Escher - Academia.edu
![PDF) Exposure-Efficacy Relationships for Vedolizumab Induction Therapy in Patients with Ulcerative Colitis or Crohn's Disease PDF) Exposure-Efficacy Relationships for Vedolizumab Induction Therapy in Patients with Ulcerative Colitis or Crohn's Disease](https://i1.rgstatic.net/publication/315612371_Exposure-Efficacy_Relationships_for_Vedolizumab_Induction_Therapy_in_Patients_with_Ulcerative_Colitis_or_Crohn's_Disease/links/5d588113a6fdccb7dc457382/largepreview.png)
PDF) Exposure-Efficacy Relationships for Vedolizumab Induction Therapy in Patients with Ulcerative Colitis or Crohn's Disease
![PDF) Treatment of complex perianal fistulas with seton and infliximab in adolescents with Crohn's disease PDF) Treatment of complex perianal fistulas with seton and infliximab in adolescents with Crohn's disease](https://i1.rgstatic.net/publication/259845979_Treatment_of_complex_perianal_fistulas_with_seton_and_infliximab_in_adolescents_with_Crohn's_disease/links/6135b619c69a4e4879814b8c/largepreview.png)
PDF) Treatment of complex perianal fistulas with seton and infliximab in adolescents with Crohn's disease
Does Fecal Calprotectin Predict Short-Term Relapse After Stopping Tnfα-Blocking Agents In Inflammatory Bowel Disease Patients I
![Patrick van Rheenen on Twitter: "Crohn's Disease treatment decision tree (after ECCO/ESPGHAN guideline) https://t.co/9KoHlv9n5g #ESPGHAN2014 http://t.co/NByj5HD7E2" / Twitter Patrick van Rheenen on Twitter: "Crohn's Disease treatment decision tree (after ECCO/ESPGHAN guideline) https://t.co/9KoHlv9n5g #ESPGHAN2014 http://t.co/NByj5HD7E2" / Twitter](https://pbs.twimg.com/media/Bp7zMunCQAE-diZ.jpg:large)
Patrick van Rheenen on Twitter: "Crohn's Disease treatment decision tree (after ECCO/ESPGHAN guideline) https://t.co/9KoHlv9n5g #ESPGHAN2014 http://t.co/NByj5HD7E2" / Twitter
![PDF) Costs and resource utilization for diagnosis and treatment during the initial year in a European inflammatory bowel disease inception cohort: an ECCO-EpiCom Study | Daniela Lazar - Academia.edu PDF) Costs and resource utilization for diagnosis and treatment during the initial year in a European inflammatory bowel disease inception cohort: an ECCO-EpiCom Study | Daniela Lazar - Academia.edu](https://0.academia-photos.com/attachment_thumbnails/48803271/mini_magick20190202-12417-owu6dm.png?1549134452)
PDF) Costs and resource utilization for diagnosis and treatment during the initial year in a European inflammatory bowel disease inception cohort: an ECCO-EpiCom Study | Daniela Lazar - Academia.edu
![PDF) Vitamin D Therapy in Inflammatory Bowel Diseases: Who, in What Form, and How Much? | Anna Krajcovicova and Tibor Hlavaty - Academia.edu PDF) Vitamin D Therapy in Inflammatory Bowel Diseases: Who, in What Form, and How Much? | Anna Krajcovicova and Tibor Hlavaty - Academia.edu](https://0.academia-photos.com/attachment_thumbnails/49658462/mini_magick20220701-11455-1duqnke.png?1656702366)
PDF) Vitamin D Therapy in Inflammatory Bowel Diseases: Who, in What Form, and How Much? | Anna Krajcovicova and Tibor Hlavaty - Academia.edu
![PDF) DOP028 Second N-ECCO Consensus Statements on the European nursing roles in caring for patients with Crohn's disease or ulcerative colitis PDF) DOP028 Second N-ECCO Consensus Statements on the European nursing roles in caring for patients with Crohn's disease or ulcerative colitis](https://i1.rgstatic.net/publication/322890443_DOP028_Second_N-ECCO_Consensus_Statements_on_the_European_nursing_roles_in_caring_for_patients_with_Crohn's_disease_or_ulcerative_colitis/links/5c7fc64592851c69505a7e20/largepreview.png)